Abstract | INTRODUCTION: Numerous therapeutic strategies are used to treat leishmaniasis. The treatment of cutaneous leishmaniasis (CL) is solely depends on antimonate derivatives with safety issues and questionable efficacy and there is no fully effective modality to treat CL caused by Leishmania tropica and Leishmania braziliensis. AREAS COVERED: EXPERT OPINION:
|
Authors | Ali Khamesipour |
Journal | Expert opinion on biological therapy
(Expert Opin Biol Ther)
Vol. 14
Issue 11
Pg. 1641-9
(Nov 2014)
ISSN: 1744-7682 [Electronic] England |
PMID | 25077737
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adjuvants, Immunologic
- Immunologic Factors
- Leishmaniasis Vaccines
|
Topics |
- Adjuvants, Immunologic
(administration & dosage)
- Animals
- Humans
- Immunologic Factors
(administration & dosage, immunology)
- Immunotherapy
(methods, trends)
- Leishmaniasis
(diagnosis, immunology, prevention & control)
- Leishmaniasis Vaccines
(administration & dosage, immunology)
- Leishmaniasis, Cutaneous
(diagnosis, immunology, prevention & control)
|